Silo Pharma, Inc. - 10-Q Filing

Silo Pharma reports Q3 2026 results featuring significant subsequent event activity including private placements and asset purchase agreements.

SEC EDGAR ·

Tickers: $SILO

Read the full article at SEC EDGAR

More Regulatory news